Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASF | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

BASF

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dr. Matthias Maase has been appointed director for BASF’s new business development operation in the company’s North American Intermediates Regional Business Unit based in Florham Park, NJ. He replaces Dr. Frank Stein, who is returning to BASF’s Ludwigshafen site to a new assignment as Group Leader for Alkylamines and Alkylalkanolamines in the BASF Intermediates division.

Dr. Maase joined the company in 1999 in the Chemicals Research & Engineering department in Ludwigshafen, Germany. His team developed and established the company’s BASIL technology, the first commercial process utilizing ionic liquids. He then served in a management position where he was responsible for the marketing of ionic liquids and ionic liquid based technologies. As recognition for their work in this field, Dr. Maase and his team were awarded the BASF Group Innovation Award in 2004, the ECN Innovation for Growth Award in 2004 and the IChemE (Institution of Chemical Engineers) Award in 2005.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters